Topoisomerase 1 Inhibition Promotes Cyclic GMP-AMP Synthase-Dependent Antiviral Responses
Open Access
- 8 November 2017
- journal article
- Published by American Society for Microbiology in mBio
- Vol. 8 (5)
- https://doi.org/10.1128/mbio.01611-17
Abstract
Inflammatory responses, while essential for pathogen clearance, can also be deleterious to the host. Chemical inhibition of topoisomerase 1 (Top1) by low-dose camptothecin (CPT) can suppress transcriptional induction of antiviral and inflammatory genes and protect animals from excessive and damaging inflammatory responses. We describe the unexpected finding that minor DNA damage from topoisomerase 1 inhibition with low-dose CPT can trigger a strong antiviral immune response through cyclic GMP-AMP synthase (cGAS) detection of cytoplasmic DNA. This argues against CPT having only anti-inflammatory activity. Furthermore, expression of the simian virus 40 (SV40) large T antigen was paramount to the proinflammatory antiviral activity of CPT, as it potentiated cytoplasmic DNA leakage and subsequent cGAS recruitment in human and mouse cell lines. This work suggests that the capacity of Top1 inhibitors to blunt inflammatory responses can be counteracted by viral oncogenes and that this should be taken into account for their therapeutic development. IMPORTANCE Recent studies suggest that low-dose DNA-damaging compounds traditionally used in cancer therapy can have opposite effects on antiviral responses, either suppressing (with the example of CPT) or potentiating (with the example of doxorubicin) them. Our work demonstrates that the minor DNA damage promoted by low-dose CPT can also trigger strong antiviral responses, dependent on the presence of viral oncogenes. Taken together, these results call for caution in the therapeutic use of low-dose chemotherapy agents to modulate antiviral responses in humans.Funding Information
- Fonds de recherche du Québec-Santé (35071)
- Department of Health | National Health and Medical Research Council (1062683)
- Department of Health | National Health and Medical Research Council (1124485)
- Australian Research Council (140100594)
This publication has 24 references indexed in Scilit:
- Mitotic progression following DNA damage enables pattern recognition within micronucleiNature, 2017
- Topoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune EvasionmBio, 2017
- Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signalingOncotarget, 2016
- Epstein-Barr VirusMicrobiology Spectrum, 2016
- Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA virusesNature Communications, 2016
- Simian Virus 40 Large T Antigen Induces IFN-Stimulated Genes through ATR KinaseThe Journal of Immunology, 2014
- Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon PathwayScience, 2013
- Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STINGNature Immunology, 2012
- Novel activity of acriflavine against colorectal cancer tumor cellsCancer Science, 2011
- The Role of Checkpoint Kinase 1 in Sensitivity to Topoisomerase I PoisonsOnline Journal of Public Health Informatics, 2005